NOTICE
ANSM - Updated on: 20/07/2017
Name of the medicinal product
BETADINE SCRUB 4%, single dose solution for skin application
framed
Read this leaflet carefully before you start using this medicine. It contains important information for your treatment.
If you have any further questions, ask your doctor or pharmacist.
· Keep this leaflet, you may need to read it again.
· If you need more information and advice, ask your pharmacist.
· If the symptoms worsen or persist, consult your doctor.
· If you notice any side effects not listed in this leaflet, or if you experience any of the effects listed as serious, please tell your doctor or pharmacist.
Review summary
In this notice :
1. WHAT IS BETADINE SCRUB 4% solution for dermal application in single-dose containers AND WHAT IT IS USED FOR?
2. BEFORE YOU USE BETADINE SCRUB 4% solution for single-dose skin application.
3. HOW TO USE BETADINE SCRUB 4% solution for dermal application in a single-dose container?
4. WHAT ARE POSSIBLE SIDE EFFECTS?
5. HOW TO STORE BETADINE SCRUB 4% solution for dermal application in a single-dose container?
6. ADDITIONAL INFORMATION
1. WHAT IS BETADINE SCRUB 4% solution for dermal application in single-dose containers AND WHAT IT IS USED FOR?
Pharmacotherapeutic group
ANTISEPTICS AND DISINFECTANTS
Therapeutic indications
This medication is an antiseptic containing iodine, it is indicated for:
· Local topical treatment and cleansing of skin and mucous membranes, infected or at risk of becoming infected.
· Antiseptic washing of the hands of the nursing staff and the hands of the surgeon.
2. BEFORE YOU USE BETADINE SCRUB 4% solution for single-dose skin application.
List of information needed before taking the medication
Not applicable.
Cons-indications
Never take BETADINE SCRUB 4% solution for single-dose skin application in the following cases:
· in the case of repeated use, from the 2nd trimester of pregnancy and in the case of breastfeeding,
· for the newborn less than 1 month,
· for the disinfection of medical and surgical equipment,
· antecedent of allergy to one of the constituents, in particular povidone. There are no cross-reactions with iodinated contrast media.
Reactions of intolerance (anaphylactoid reactions) to iodinated contrast media or seafood anaphylaxis do not constitute a contraindication to the use of BETADINE SCRUB 4%.
This medication MUST NOT BE GENERALLY USED, unless otherwise advised by your doctor, in the following cases:
· in combination with mercury-derived antiseptics.
IN CASE OF DOUBT, IT IS ESSENTIAL TO ASK FOR THE OPINION OF YOUR DOCTOR OR YOUR PHARMACIST.
Precautions for use; special warnings
Take special care with BETADINE SCRUB 4% solution for skin application in single-dose containers:
Special warnings
Special attention is required for routine applications to injured skin in patients with renal insufficiency, especially in severe burns ( see Adverse effects ).
The iodine contained in this medicinal product may pass through the skin, particularly in the case of repeated use or on certain fragile or fragile skin and pass into the general circulation (undesired and troublesome effects).
Use in children under 30 months of age requires PRIOR NOTICE OF YOUR DOCTOR OR YOUR PHARMACIST.
IN CASE OF DOUBT DO NOT HESITATE TO ASK FOR THE OPINION OF YOUR DOCTOR OR YOUR PHARMACIST
Precautions for use
Rinse after use.
Avoid dripping. Prolonged contact with undried solution may cause irritation and rarely severe burn-type skin reactions.
Interaction with other medicines
Taking or using other medicines
Avoid simultaneous or sequential use of different antiseptics.
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, talk to your doctor or pharmacist.
Interactions with food and beverages
Not applicable.
Interactions with Herbal Medicines or Alternative Therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy
Due to the presence of iodine, the use of this drug, in the case of repeated use , is contraindicated from the 2nd trimester.
It will only be used occasionally on the advice of your doctor.
Ask your doctor or pharmacist for advice before taking any medicine.
feeding
Breast-feeding is contraindicated if repeated use of this medication is used.
Ask your doctor or pharmacist for advice before taking any medicine.
Sport
Not applicable.
Effects on ability to drive or use machines
Not applicable.
List of excipients with known effect
Not applicable.
3. HOW TO USE BETADINE SCRUB 4% solution for dermal application in a single-dose container?
Instructions for proper use
Not applicable.
Dosage, Mode and / or route (s) of administration, Frequency of administration and Duration of treatment
Administration mode
Dermal.
Dosage
For handwashing, the product is used purely at the rate of 4 ml poured on the wet hands. Scrub for 1 min and rinse thoroughly with water.
For surgical handwashing, repeat this procedure for 3 to 5 minutes, on the hands and forearms.
For the washing of soiled wounds, use the product diluted to one third . Rinse thoroughly with water.
Symptoms and Instructions for Overdose
Not applicable.
Instructions for omission of one or more doses
Not applicable.
Risk of withdrawal syndrome
Not applicable.
4. WHAT ARE POSSIBLE SIDE EFFECTS?
Description of adverse reactions
Like all medicines, this medicine may cause side effects, although not everybody gets them.
· In case of repeated and prolonged use on certain fragile or fragile skins especially in the premature and the big burned, an overload of iodine may occur which can modify the functioning of the thyroid gland.
· Local skin reactions may occur: burning-type caustic dermatitis in case of maceration and contact dermatitis.
· Possibility of skin irritation and local allergic reaction.
· a reversible and transient coloration may appear on the skin.
· exceptionally general allergic reactions: urticaria, angioedema, anaphylactic shock, anaphylactoid reaction have been described with products containing povidone including BETADINE SCRUB 4%.
· When used on large surfaces and in severe burns, general effects such as impaired renal function have been observed.
Declaration of side effects
If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and network of Regional Centers of Pharmacovigilance - Website: www.ansm.sante.fr
By reporting adverse reactions, you are helping to provide more information about the safety of the drug.
5. HOW TO STORE BETADINE SCRUB 4% solution for dermal application in a single-dose container?
Keep out of the reach and sight of children.
Expiration date
Do not use BETADINE SCRUB 4% solution for single dose skin application after the expiry date which is stated on the vial.
Storage conditions
Store at a temperature not exceeding 25 ° C.
If necessary, warnings against visible signs of deterioration
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist what to do with unused medications. These measures will help protect the environment.
6. ADDITIONAL INFORMATION
Full list of active substances and excipients
What does BETADINE SCRUB 4% contain, solution for single-dose skin application?
The active substance is:
Povidone iodine ................................................ .................................................. ................................ 0.40 g
For a single-dose container of 10 ml.
The other components are:
A 60% ammonium salt solution of the alkylphenoxypolyethylene ethane sulfuric ester (ammonium salt of alkylphenoxypolyethylene ethane sulfuric ester, ethanol denatured ethanol, purified water), lauric acid condensate and diethanolamine, sodium hydroxide, purified water.
Pharmaceutical form and content
What is BETADINE SCRUB 4% solution for dermal application in single-dose containers and contents of the pack?
This medication is in the form of a solution for skin application. Box of 5, 10, 50 or 100 single-dose containers.
Name and address of the marketing authorization holder and the holder of the manufacturing authorization responsible for the release of the lots, if different
Holder
MEDA PHARMA
40-44 WASHINGTON STREET
75008 PARIS
exploiting
MYLAN MEDICAL SAS
40-44 Washington Street
75008 PARIS
Maker
MEDA MANUFACTURING
AVENUE JF KENNEDY
33700 MERIGNAC
Names of the medicinal product in the Member States of the European Economic Area
Not applicable.
Date of approval of the notice
The last date on which this leaflet was approved is {date}.
AMM under exceptional circumstances
Not applicable.
Internet Information
Detailed information on this medicine is available on the ANSM website (France).
Information for health professionals only
Not applicable.
Other
Not applicable.